Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine Augmentation for GAD and SAD
NCT00411398Phase 3Completed
- Sponsor
- Upstate Medical University
- Start
- Dec 2006
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of memantine in generalized anxiety disorder (GAD), Social Anxiety Disorder (SAD), sponsored by Upstate Medical University. Started Dec 2006; status: completed.
02
Drugs
memantine
03
Conditions
generalized anxiety disorder (GAD)Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00411398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411398.